conjunctivitis, allergic

Showing 1 - 22 of 22

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Food-specific IgG4-guided Elimination Diets Improve Allergy

Completed
  • Rhinitis, Allergic
  • +4 more
    • Hangzhou, Zhejiang, China
      Second Affiliated Hospital,School of Medicine,Zhejiang Universit
    Sep 25, 2023

    Conjunctivitis, Allergic Trial in United States (ADX-102 Ophthalmic Drops (0.5%), ADX-102 Ophthalmic Drops (0.1%), Vehicle of

    Completed
    • Conjunctivitis, Allergic
    • ADX-102 Ophthalmic Drops (0.5%)
    • +2 more
    • Morrow, Georgia
    • +4 more
    Dec 14, 2022

    Rhinitis, Allergic, Conjunctivitis, Allergic, Asthma Trial in Stockholm (Subcutaneous immunotherapy with ALK Alutard birch or

    Completed
    • Rhinitis, Allergic
    • +2 more
    • Subcutaneous immunotherapy with ALK Alutard birch or ALK Alutard timothy
    • No immunotherapy, symptomatic treatment
    • Stockholm, Sweden
      Karolinska University Hospital
    Apr 3, 2022

    Conjunctivitis, Allergic Trial (desloratadine)

    Completed
    • Conjunctivitis, Allergic
    • (no location specified)
    Feb 7, 2022

    Conjunctivitis, Allergic, Conjunctivitis, Vernal Trial in Montréal (Hyaluronic acid 0.05% & Ectoine 2.0%, Olopatadine HCl

    Recruiting
    • Conjunctivitis, Allergic
    • Conjunctivitis, Vernal
    • Hyaluronic acid 0.05% & Ectoine 2.0%
    • Olopatadine hydrochloride ophthalmic solution 0.1%
    • Montréal, Quebec, Canada
      CHU Sainte-Justine Hospital
    Oct 20, 2020

    Conjunctivitis, Allergic Trial in Rochester (Mapracorat, Vehicle)

    Completed
    • Conjunctivitis, Allergic
    • Rochester, New York
      Bausch & Lomb
    Sep 2, 2020

    Conjunctivitis, Allergic Trial in Mississauga (Reproxalap Ophthalmic Solution (0.25%), Reproxalap Ophthalmic Solution (0.5%),

    Completed
    • Conjunctivitis, Allergic
    • Reproxalap Ophthalmic Solution (0.25%)
    • +2 more
    • Mississauga, Ontario, Canada
      Inflamax Research Limited
    May 11, 2020

    Corneal Biomechanical Changes of Allergic Conjunctivitis

    Unknown status
    • Conjunctivitis, Allergic
    • Keratoconus
      • Guangzhou, China
        Zhongshan Ophthalmic Center, Sun Yat-Sen University
      Mar 3, 2020

      Lastacaft® for Prevention of Itching Associated With Allergic

      Completed
      • Conjunctivitis, Allergic
      • Alcaftadine Ophthalmic Solution 0.25%
      • Busan, Korea, Republic of
      • +80 more
      Jul 2, 2019

      Conjunctivitis, Allergic Trial in Tokyo (AGN-229666, Vehicle to AGN-229666, Olopatadine)

      Completed
      • Conjunctivitis, Allergic
      • Tokyo, Japan
        (unnamed)
      Apr 9, 2019

      Ocular Itching, Ocular Allergy, Seasonal Allergic Conjunctivitis Trial in Guadalajara, Mexico City (PRO-118 Ophthalmic Solution

      Withdrawn
      • Ocular Itching
      • +4 more
      • PRO-118 Ophthalmic Solution 0.015%
      • +3 more
      • Guadalajara, Jalisco, Mexico
      • +1 more
      Oct 1, 2018

      Conjunctivitis, Allergic Trial in Tokyo (AGN-229666)

      Completed
      • Conjunctivitis, Allergic
      • Tokyo, Japan
        (unnamed)
      Feb 11, 2016

      Relestat Ophthalmic Solution 0.05% for Allergic Conjunctivitis

      Completed
      • Conjunctivitis, Allergic
      • Relestat Ophthalmic Solution 0.05%
      • Gangwon-do, Korea, Republic of
        (unnamed)
      Mar 26, 2014

      Conjunctivitis, Allergic Trial in Memphis (Alcaftadine 0.25%, Olopatadine 0.2%, dextran 70 0.1%/hydroxypropyl methylcellulose

      Completed
      • Conjunctivitis, Allergic
      • Alcaftadine 0.25%
      • +2 more
      • Memphis, Tennessee
        (unnamed)
      Nov 27, 2013

      Conjunctivitis, Allergic Trial in Philadelphia (alcaftadine 0.25% ophthalmic solution, olopatadine 0.2% ophthalmic solution,

      Completed
      • Conjunctivitis, Allergic
      • alcaftadine 0.25% ophthalmic solution
      • +2 more
      • Philadelphia, Pennsylvania
        (unnamed)
      Jan 18, 2013

      Conjunctivitis, Allergic Trial in Irvine (Bepreve, Placebo, Bepotastine Besilate)

      Completed
      • Conjunctivitis, Allergic
      • Irvine, California
        ISTA Pharmaceuticals, Inc.
      Feb 13, 2013

      Rhinitis, Allergic, Seasonal, Conjunctivitis, Allergic Trial in Worldwide (SUBLIVAC® Grasses/Placebo treatment, SUBLIVAC®

      Completed
      • Rhinitis, Allergic, Seasonal
      • Conjunctivitis, Allergic
      • SUBLIVAC® Grasses/Placebo treatment
      • +2 more
      • Antwerp, Belgium
      • +59 more
      Feb 6, 2012

      Rhinitis, Allergic, Seasonal, Conjunctivitis, Allergic Trial in Bangalore (olopatadine HCl /ketorolac tromethamine fixed dose

      Completed
      • Rhinitis, Allergic, Seasonal
      • Conjunctivitis, Allergic
      • olopatadine hydrochloride /ketorolac tromethamine fixed dose combination ophthalmic solution
      • olopatadine hydrochloride 0.1% ophthalmic solution
      • Bangalore, Karnataka, India
        (unnamed)
      Jan 24, 2012

      Rhinitis, Allergic, Seasonal, Conjunctivitis, Allergic Trial in Cádiz (Standardization of allergenic extract (Gly. domesticus))

      Completed
      • Rhinitis, Allergic, Seasonal
      • Conjunctivitis, Allergic
      • Standardization of allergenic extract (Gly. domesticus)
      • Cádiz, Cadiz, Spain
        Clinica Dr. Lobatón
      Jun 17, 2011

      Rhinitis, Allergic, Seasonal, Conjunctivitis, Allergic, Asthma Trial in Salamanca (Immunotherapy with modified extract of P.

      Completed
      • Rhinitis, Allergic, Seasonal
      • +2 more
      • Immunotherapy with modified extract of P. pratense pollen
      • Placebo
      • Salamanca, Spain
        Hospital Clínico de Salamanca
      Dec 16, 2010

      Rhinitis, Allergic, Seasonal, Conjunctivitis, Allergic Trial in Calde (Standardization of allergenic extract (Ch. arcuatus))

      Completed
      • Rhinitis, Allergic, Seasonal
      • Conjunctivitis, Allergic
      • Standardization of allergenic extract (Ch. arcuatus)
      • Calde, Lugo, Spain
        Hospital "Xeral de Calde"
      Aug 4, 2010

      Conjunctivitis, Allergic Trial in North Andover (Olopatadine, Fluticasone, Saline)

      Completed
      • Conjunctivitis, Allergic
      • North Andover, Massachusetts
        Ophthalmic Research Associates, Inc
      Apr 2, 2008